Abatacept - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ORENCIA abatacept (rch) 125 mg single dose ClickJect prefilled autoinjector
AUST R: 236039
Active ingredients:
Abatacept

Dosage form:
Injection

Sponsor:
Bristol-Myers Squibb Australia Pty Ltd

Phone:
1800 067 567

From
03 Jun 2024
to
30 Aug 2024

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
The sponsor is closely controlling the supply. The TGA is working to develop a management strategy. A TGA web alert is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-2024-shortage-orencia-abatacept-medicines
ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection ultrasafe passive needle guard and flange extender
AUST R: 206764
Active ingredients:
Abatacept

Dosage form:
Injection

Sponsor:
Bristol-Myers Squibb Australia Pty Ltd

Phone:
1800 067 567

From
17 Jun 2024
to
30 Sep 2024

Shortage status:
Anticipated

Availability:
Available

Reason:
Unexpected increase in consumer demand

Management action:
The sponsor is closely controlling the supply. The TGA is working to develop a management strategy. A TGA web alert is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-2024-shortage-orencia-abatacept-medicines